NASDAQ: MYSEMyseum Inc Stock
$2.66+0.37 (+16.16%)
Updated Aug 8, 2025
MYSE Price
$2.66
Fair Value Price
$0.40
Market Cap
$11.18M
52 Week Low
$1.11
52 Week High
$9.34
P/E
-1.91x
P/B
1.09x
P/S
40,682.97x
PEG
N/A
Dividend Yield
N/A
Revenue
$388.00
Earnings
-$4.57M
Gross Margin
100%
Operating Margin
-1,179,006.19%
Profit Margin
-1,179,006.2%
Debt to Equity
0.07
Operating Cash Flow
-$4M
Beta
1.06
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MYSE Overview
DatChat, Inc. offers DatChat Messenger & Private Social Network, a mobile application that gives users the ability to communicate with privacy and protection. It is developing a blockchain-based, decentralized communications platform that allows consumers and businesses to connect directly with each other. DatChat was incorporated in 2014 and is based in New Brunswick, NJ.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MYSE's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important MYSE news, forecast changes, insider trades & much more!
MYSE News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MYSE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MYSE ($2.66) is overvalued by 558.21% relative to our estimate of its Fair Value price of $0.40 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
MYSE ($2.66) is not significantly undervalued (558.21%) relative to our estimate of its Fair Value price of $0.40 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
MYSE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MYSE due diligence checks available for Premium users.
Valuation
MYSE fair value
Fair Value of MYSE stock based on Discounted Cash Flow (DCF)
Price
$2.66
Fair Value
$0.40
Overvalued by
559.45%
MYSE ($2.66) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MYSE ($2.66) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MYSE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
MYSE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.91x
Industry
33.58x
Market
36.48x
MYSE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.09x
Industry
6.63x
MYSE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MYSE's financial health
Profit margin
Revenue
$83.0
Net Income
-$1.5M
Profit Margin
-1,774,934.9%
MYSE's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
MYSE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$8.5M
Liabilities
$699.4k
Debt to equity
0.07
MYSE's short-term assets ($7.21M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MYSE's short-term assets ($7.21M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MYSE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.4M
Investing
-$2.9M
Financing
$4.4M
MYSE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
MYSE vs App Stocks
Myseum Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.